What are the differences between Mydayis (mixed amphetamine salts) and Adderall (mixed amphetamine salts) regarding formulation, dosing, duration of effect, and approved age groups?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mydayis vs. Adderall: Key Differences

Mydayis and Adderall are both mixed amphetamine salt formulations, but Mydayis is a triple-bead extended-release formulation designed for up to 16 hours of effect and approved only for ages 13 and older, while Adderall XR (extended-release) provides approximately 12 hours of coverage and is approved for children as young as 6 years. 1

Duration of Action

The most clinically significant difference is duration:

  • Mydayis: Provides symptom control for up to 16 hours post-dose, with demonstrated efficacy from 2-4 hours through 16 hours in clinical trials 1, 2
  • Adderall XR: Provides symptom control for approximately 12 hours, with documented efficacy at 4 and 12 hours post-dose 3

This extended duration makes Mydayis particularly useful for patients requiring late afternoon and evening symptom coverage, addressing a common gap in standard extended-release formulations 2.

Formulation Technology

  • Mydayis: Uses a triple-bead delivery system with three distinct release phases to achieve its extended 16-hour duration 1, 2
  • Adderall XR: Uses a dual-bead system combining immediate-release and delayed-release beads for 12-hour coverage 3

Approved Age Groups

This is a critical prescribing distinction:

  • Mydayis: FDA-approved only for ages 13 years and older (adolescents and adults). Explicitly NOT approved for children 12 years and younger 1
  • Adderall XR: FDA-approved for ages 6 years and older, including younger children 4, 5

Dosing

Mydayis 1:

  • Starting dose: 12.5 mg once daily in the morning
  • Available doses: 12.5 mg, 25 mg, 37.5 mg, 50 mg
  • Maximum adult dose: 50 mg/day
  • Single morning dose only due to 16-hour duration

Adderall XR 3, 4:

  • Typical starting dose: 10 mg once daily
  • Dose range: 10-40 mg/day in adolescents; 20-60 mg/day in adults
  • Single morning dose

Clinical Efficacy

Both medications demonstrate robust efficacy as first-line ADHD treatments 6:

  • Mydayis: Showed statistically significant improvements in ADHD-RS-IV scores across all approved doses (12.5-50 mg) with effect sizes around 0.8, with the unique advantage of maintaining efficacy through evening hours 1, 2
  • Adderall XR: Demonstrated mean effect size of 0.8 with significant symptom reduction maintained over 24 months of treatment 3, 5

Pharmacokinetics

Mydayis produces approximately 21-31% higher peak concentrations (Cmax) and total exposure (AUC) in adolescents (ages 13-17) compared to adults at equivalent doses, requiring careful dose titration in younger patients 1.

Common Pitfalls

  1. Age restriction violation: Do not prescribe Mydayis to children under 13 years—use Adderall XR or other approved formulations instead
  2. Timing errors: Both must be taken in the morning upon waking; Mydayis especially cannot be taken later due to its 16-hour duration causing insomnia 1
  3. Missed dose management: If a dose is missed, do NOT take later in the day or double the next dose—skip and resume normal schedule 1
  4. Duration expectations: Patients switching from Adderall XR to Mydayis should be counseled about the extended 16-hour coverage to avoid evening rebound concerns

Safety Profile

Both medications share similar adverse effect profiles typical of amphetamine stimulants 6, 1:

  • Decreased appetite (most common)
  • Insomnia
  • Headache
  • Increased blood pressure and heart rate
  • Abdominal pain

Both are Schedule II controlled substances with abuse potential and require the same cardiovascular and psychiatric monitoring 1.

Clinical Decision-Making

Choose Mydayis when:

  • Patient is ≥13 years old
  • Extended coverage into evening hours is needed (homework, after-school activities, evening family functioning)
  • Patient has documented afternoon/evening symptom breakthrough on 12-hour formulations

Choose Adderall XR when:

  • Patient is 6-12 years old (Mydayis not approved)
  • 12-hour coverage is sufficient
  • Cost is a significant factor (Adderall XR has generic availability)

Related Questions

What are the FDA‑approved generic manufacturers of Adderall XR (mixed amphetamine salts) and their reported efficacy and potency?
What is the maximum recommended daily dose of Adderall (mixed amphetamine salts) for children aged six years and older and adults?
How should the dose of Adderall XR (mixed amphetamine salts) 10 mg be adjusted when it does not provide full daytime coverage, and when and how should a short‑acting (immediate‑release) amphetamine be added?
Is it safe to take Adderall (mixed amphetamine salts) 40 mg extended‑release in the morning together with 20 mg immediate‑release in the morning?
What is the maximum recommended daily dose of Adderall (mixed amphetamine salts) for ADHD and narcolepsy in children, adolescents, and adults?
Can meropenem be combined with ampicillin for empiric treatment of Klebsiella pneumoniae and Enterococcus infections?
How should lumbar spine bone mineral density values for vertebrae L1 through L4 be interpreted?
After rapidly increasing sertraline (Zoloft) to 100 mg and experiencing severe side effects for social anxiety, how should I safely discontinue the medication and what taper schedule is recommended?
What is the recommended initial management for a 70-year-old female with a rupture of the long head of the biceps tendon?
What does a positive drug screen for opiates, cocaine, and oxycodone indicate in a patient receiving oxycodone, tramadol, and acetaminophen (Tylenol) in the hospital and taking Norco (hydrocodone/acetaminophen) at home?
What is the radiation dose from a bone mineral density (BMD) test such as dual‑energy X‑ray absorptiometry (DXA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.